India CL Case Seen Increasing Global Pharma Pressure For IP Protection
This article was originally published in PharmAsia News
With South Africa's recent expression of interest in following India's lead in enforcing compulsory licensing, Western pharmaceutical companies see a confirmation of their fear the idea will spread throughout emerging markets.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?